Key points are not available for this paper at this time.
Dendrimers synthesized from small molecules form macromolecules of well-defined size and architecture.1 The high density of functional groups on the periphery of the dendrimers makes them useful as carriers for multiple copies of biologically active compounds for drug/vaccine delivery or probe molecules for detection applications.2 However, the typical synthetic procedure for obtaining dendrimers from small molecules limits their size to about 5−15 nm as each new generation is increasingly difficult to add and contributes only to a relatively small increase in dimensions. In addition, traditional dendrimers are difficult to purify and as a consequence costly. Thus, the focus in synthetic dendrimers has shifted from using small molecule to polymeric building blocks made by living radical polymerization.3 However, there is still a need in precise synthetic tools that would allow one to combine polymeric blocks with diverse functionality into one structure to create advanced products for biomedical and coatings applications.
Urbani et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: